-
psnet.ahrq.gov/node/60196/psn-pdf
April 01, 2020 - This news story discussed the
shortage of protective masks for pharmacists and the potential unintended
-
psnet.ahrq.gov/node/838255/psn-pdf
October 05, 2022 - Speakers participating in this webinar discussed the impact of errors on families, adverse event
prevalence
-
psnet.ahrq.gov/node/866905/psn-pdf
October 09, 2024 - dual-process-models-clinical-reasoning-central-role-knowledge-diagnostic-
expertise
Diagnostic reasoning is frequently discussed
-
psnet.ahrq.gov/node/37020/psn-pdf
July 24, 2008 - A previous
WebM&M commentary discussed a tubing error that led to administration of the wrong gas.
-
psnet.ahrq.gov/node/856592/psn-pdf
January 01, 2024 - Risk assessments and categorization (e.g., high- or low-risk) were discussed in
conjunction with strategies
-
meps.ahrq.gov/survey_comp/hc_survey/paper_quest/2011/CancerSAQ_En.pdf
January 01, 2011 - Discussed it with me in detail
Briefly discussed it with me
Did not discuss it at all
I … Discussed it with me in detail
Briefly discussed it with me
Did not discuss it at all
I … Discussed it with me in detail
Briefly discussed it with me
Did not discuss it at all
I … Discussed it with me in detail
Briefly discussed it with me
Did not discuss it at all
I
-
meps.ahrq.gov/survey_comp/hc_survey/paper_quest/2011/CancerSAQ_En.shtml
January 01, 2011 - Discussed it with me in detail .
Briefly discussed it with me.
… Discussed it with me in detail .
Briefly discussed it with me.
… Discussed it with me in detail .
Briefly discussed it with me.
… Discussed it with me in detail .
Briefly discussed it with me.
-
cds.ahrq.gov/sites/default/files/workgroups/1261/CDS_Connect_WG_%20March2021_%20Summary.pdf
March 18, 2021 - They suggested illustrating the bidirectionality of the partnering relationship, as
discussed by Mr. … discussion may be
very technical, or should a parallel call be held instead where the topic in question is discussed … What’s New with CDS Connect
The MITRE team discussed updates and features that were recently implemented
-
psnet.ahrq.gov/node/865523/psn-pdf
April 10, 2024 - Perceived safety in the context of ethics, economics, transparency, and more are also discussed.
-
psnet.ahrq.gov/node/865723/psn-pdf
June 18, 2024 - Presenters discussed the survey results, how SOPS
resources were used, and their focus on initiatives
-
psnet.ahrq.gov/node/865971/psn-pdf
May 29, 2024 - Strategies to address
challenges are discussed.
-
psnet.ahrq.gov/node/36395/psn-pdf
May 04, 2015 - https://psnet.ahrq.gov/issue/introduction-improved-fda-prescription-drug-labeling
This teleconference discussed
-
psnet.ahrq.gov/node/837668/psn-pdf
July 13, 2022 - Subcategories and contributing factors are also discussed.
-
psnet.ahrq.gov/node/48105/psn-pdf
July 10, 2019 - A
WebM&M commentary discussed an incident involving a medical student who failed to report an error.
-
psnet.ahrq.gov/node/72818/psn-pdf
March 10, 2021 - community pharmacies in England, the authors found that polypharmacy was a
pervasive problem but rarely discussed
-
psnet.ahrq.gov/node/844794/psn-pdf
January 01, 2020 - The strategies discussed center on the importance of organizational communication to
patients, navigating
-
psnet.ahrq.gov/node/60519/psn-pdf
May 27, 2020 - communication)
and state/federal guidance around testing and monitoring diagnostic performance are also discussed
-
psnet.ahrq.gov/node/849601/psn-pdf
May 31, 2023 - Challenges associated
with the COVID-19 pandemic are also discussed.
-
psnet.ahrq.gov/node/48040/psn-pdf
July 24, 2019 - A WebM&M
commentary discussed strategies for safer medication management for older patients.
-
psnet.ahrq.gov/node/855095/psn-pdf
November 08, 2023 - Participants discussed several challenges, such as patient location (particularly
for patients in isolation